Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal Trends, Players and Financials; New Report Launched
The Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the cancer monoclonal antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
View full press release